Specific country notes have been prepared using data from the database OECD Health Statistics 2015, July 2015 version. The notes are available in PDF format.
The OECD/Korea Policy Centre fosters the exchange of technical information and policy experiences relating to the Asia Pacific region in areas such as health statistics, pension reforms and social policy and expenditure.
English, PDF, 386kb
한국의 GDP 대비 국민의료비 비중은 2000년 4.5% 에서 2010년 처음으로 7%을 넘은 것(7.1%)으로 나타났다. 그러나 한국의 GDP 대비 국민의료비 비중 7.1%는 OECD 평균 9.5 %에 비해서는 낮은 편이다. 미국은 GDP 대비 17.6%로 가장 높다.
Those in-depth studies of the health system of member countries focus on economic issues. They assess the performance of health systems in a comparative context, identify the main challenges faced by the country health system and put forward policy options to better meet them. Reviews are initiated at the request of the country to be examined and emphasis is placed on specific issues of key policy interest.
At a time when ever more information is available about the quality of health care, the challenge for policy makers is to better understand the policies and approaches that sit behind the numbers. Korea is the first country report in a new OECD series evaluating the quality of health care across OECD countries – whether care is safe, effective and responsive to patients’ needs. OECD Reviews of Health Care Quality examine
A new OECD series of Health Care Quality Reviews opens with a review of Korea.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.
This summary study looks at existing Korean family, health and pension policies from an international perspective and considers them in view of the emerging policy challenges in Korea. It was presented at a policy forum on Low fertility and Ageing Society, in September 2006 in Seoul.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.